Reid G. Adler - Net Worth and Insider Trading
Reid G. Adler Net Worth
The estimated net worth of Reid G. Adler is at least $52,982 dollars as of 2024-04-28. Reid G. Adler is the CHIEF LEGAL OFFICER of Vistagen Therapeutics Inc and owns about 11,154 shares of Vistagen Therapeutics Inc (VTGN) stock worth over $52,982. Details can be seen in Reid G. Adler's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Reid G. Adler has not made any transactions after 2022-08-17 and currently still holds the listed stock(s).
Transaction Summary of Reid G. Adler
Reid G. Adler Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Reid G. Adler owns 1 companies in total, including Vistagen Therapeutics Inc (VTGN) .
Click here to see the complete history of Reid G. Adler’s form 4 insider trades.
Insider Ownership Summary of Reid G. Adler
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
VTGN | Vistagen Therapeutics Inc | 2022-08-17 | CHIEF LEGAL OFFICER |
Reid G. Adler Latest Holdings Summary
Reid G. Adler currently owns a total of 1 stock. Reid G. Adler owns 11,154 shares of Vistagen Therapeutics Inc (VTGN) as of August 17, 2022, with a value of $52,982.
Latest Holdings of Reid G. Adler
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
VTGN | Vistagen Therapeutics Inc | 2022-08-17 | 11,154 | 4.75 | 52,982 |
Holding Weightings of Reid G. Adler
Reid G. Adler Form 4 Trading Tracker
According to the SEC Form 4 filings, Reid G. Adler has made a total of 1 transactions in Vistagen Therapeutics Inc (VTGN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Vistagen Therapeutics Inc is the acquisition of 10,000 shares on August 17, 2022, which cost Reid G. Adler around $51,000.
Insider Trading History of Reid G. Adler
- 1
Reid G. Adler Trading Performance
GuruFocus tracks the stock performance after each of Reid G. Adler's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Reid G. Adler is -24.55%. GuruFocus also compares Reid G. Adler's trading performance to market benchmark return within the same time period. The performance of stocks bought by Reid G. Adler within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Reid G. Adler's insider trading performs compared to the benchmark.
Performance of Reid G. Adler
Average Return
-4.37%
Outperforming Transactions
0%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | -1.09 | -24.55 | 1.97 | -4.37 | ||
Relative Return to S&P 500(%) | 8.29 | -16.89 | 6.53 | -6.62 |
Reid G. Adler Ownership Network
Ownership Network List of Reid G. Adler
Ownership Network Relation of Reid G. Adler
Reid G. Adler Owned Company Details
What does Vistagen Therapeutics Inc do?
Who are the key executives at Vistagen Therapeutics Inc?
Reid G. Adler is the CHIEF LEGAL OFFICER of Vistagen Therapeutics Inc. Other key executives at Vistagen Therapeutics Inc include Chief Operating Officer Joshua S. Prince , CHIEF FINANCIAL OFFICER Cynthia Lynn Anderson , and 10 percent owner Commodore Capital Lp .
Vistagen Therapeutics Inc (VTGN) Insider Trades Summary
Over the past 18 months, Reid G. Adler made no insider transaction in Vistagen Therapeutics Inc (VTGN). Other recent insider transactions involving Vistagen Therapeutics Inc (VTGN) include a net purchase of 775,756 shares made by Commodore Capital Lp ,
In summary, during the past 3 months, insiders sold 0 shares of Vistagen Therapeutics Inc (VTGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vistagen Therapeutics Inc (VTGN) were sold and 775,756 shares were bought by its insiders, resulting in a net purchase of 775,756 shares.
Vistagen Therapeutics Inc (VTGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vistagen Therapeutics Inc Insider Transactions
Reid G. Adler Mailing Address
Above is the net worth, insider trading, and ownership report for Reid G. Adler. You might contact Reid G. Adler via mailing address: C/o Vistagen Therapeutics, Inc., 343 Allerton Ave., South San Francisco Ca 94090.